리브스메드

491000KOSDAQ의료용 기기 제조업

46.5 / 100

Reference Date: 2026-06-10

Financial Score13.5 / 40

News Sentiment19.0 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 36.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Livsmed develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, leveraging its proprietary 90° multi-joint technology to offer products like ArtiSential and ArtiSeal. The company has obtained major international certifications and aims to provide comprehensive solutions in the global minimally invasive surgery market.

Number of Employees

334people

Average Salary

44.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 21.514.0Point

PBR

5.67Industry Average 1.380.0Point

4.1x industry avg (risky)

ROE

-20.75Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

4.02Industry Average 11.656.5Point

Half of industry avg (excellent)

Trend 3.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

0.0 / 4

Detailed News Sentiment

13 totalPositive 10Neutral 3Negative 0Average Sentiment Score 76.2

Positive
베일 벗은 리브스메드 비밀병기…다빈치·휴고 라스와 차별점은?
리브스메드의 다관절 복강경 수술로봇 스타크 공개로 주력 제품의 혁신적 기능 강화 기대.
Neutral
레버리지 출격한 삼전닉스…하나만 고르라면? [한경 프리미엄9 TODAY...
삼성전자와 SK하이닉스의 시가총액 격차가 줄어들었으나, 직접적인 영향은 리브스메드에 미치지 않음.
Positive
리브스메드 "스타크, 로봇수술 접근성 높여 미개척 시장 차지할 것"
리브스메드의 로봇수술 시스템 '스타크' 출시로 국내 시장 개척 및 글로벌 진출이 예상되어 긍정적인 전망.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 41,050Won52-week high 91,30052-week low 41,050

1-month return0.0Point

1m -36.46% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral분기보고서 (2026.03)2026-05-15
Neutral주요사항보고서(유형자산양수결정)2026-05-13
Neutral[첨부정정]주요사항보고서(유형자산양수결정)2026-05-13